The Food and Drug Administration (FDA) has approved the Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease. This approval marks the fourth blood test for Alzheimer's that the FDA has authorized in less than two years. Roche announced the approval on Sunday.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
FDA Approves Elecsys Phospho-Tau Blood Test for Alzheimer's Disease
The FDA has approved the Elecsys Phospho-Tau blood test for diagnosing Alzheimer's disease, marking the fourth such approval in under two years. Roche made the announcement on August 24, 2026.
Companies
Roche
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
FDA approves new blood test for Alzheimer’s disease
Neutral Headline
FDA Approves Elecsys Phospho-Tau Blood Test for Alzheimer's Disease